The natural history of renal function following orthotopic heart transplant

Clinical Transplantation

Volumn 19, Issue 5, 2005, Pages 683-689

  Aly, Ziyad Al ^a   Abbas, Samer ^b   Moore, Eric ^b   Diallo, Ousmane ^c   Hauptman, Paul J ^a   Bastani, Bahar ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

Calcineurin inhibitors; Cardiac transplant; Chronic kidney disease; Cyclosporine; Nephrotoxicity; Orthotopic heart transplant; Renal failure; Renal function

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; OKT 3; THYMOCYTE ANTIBODY;

ADULT; AGE; ARTICLE; CARDIAC GRAFT REJECTION; CHRONIC KIDNEY FAILURE; CLINICAL OBSERVATION; DEATH; DIABETES MELLITUS; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EXPOSURE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DISEASE; HEART GRAFT; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHROTOXICITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL TIME; UNITED STATES; UNIVERSITY HOSPITAL;

ADULT; CYCLOSPORINE; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 25144470251     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2005.00408.x     Document Type: Article

References (46)

1. El Kossi MM, Ibrahim A, Lock TJ, El Nahas AM. Impact of cardiac transplantation on kidney function: a single- center experience. Transplant Proc 2003: 35: 1527.
2. van Gelder T, Balk AH, Zietse R, Hesse C, Mochtar B, Weimar W. Renal insufficiency after heart transplantation: a case-control study. Nephrol Dial Transplant 1998: 13: 2322.
3. Waser M, Maggiorini M, Binswanger U et al. Irreversibility of cyclosporine-induced renal function impairment in heart transplant recipients. J Heart Lung Transplant 1993: 12: 846.
4. Greenberg A, Thompson ME, Griffith BJ et al. Cyclosporine nephrotoxicity in cardiac allograft patients - a seven-year follow-up. Transplantation 1990: 50: 589.
5. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: incidence and progression. Transplantation 1997: 63: 664.
6. Zaltzman JS, Pei Y, Maurer J, Patterson A, Cattran DC. Cyclosporine nephrotoxicity in lung transplant recipients. Transplantation 1992: 54: 875.
7. Greenberg A, Egel JW, Thompson ME et al. Early and late forms of cyclosporine nephrotoxicity: studies in cardiac transplant recipients. Am J Kidney Dis 1987: 9: 12.
8. McKenzie N, Keown P, Stiller C, Kostuk W, Campbell C, Keith F. Effects of cyclosporine on renal function following orthotopic heart transplantation. J Heart Transplant 1985: 4: 400.
9. Devineni R, McKenzie N, Keown P, Kostuk W, Stiller C, Silver M. Cyclosporine in cardiac transplantation. Can J Surg 1984: 27: 252.
10. Ziolkowski J, Paczek L, Senatorski G et al. Renal function after liver transplantation: calcineurin inhibitor nephrotoxicity. Transplant Proc 2003: 35: 2307.
11. Lynn M, Abreo K, Zibari G, McDonald J. End-stage renal disease in liver transplants. Clin Transplant 2001: 15 (Suppl. 6): 66.
12. Platz KP, Mueller AR, Blumhardt G et al. Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. Transpl Int 1994: 7 (Suppl. 1): S52.
13. Platz KP, Mueller AR, Blumhardt G et al. Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. Transplantation 1994: 58: 170.
14. Pattison JM, Petersen J, Kuo P, Valantine V, Robbins RC, Theodore J. The incidence of renal failure in one hundred consecutive heart-lung transplant recipients. Am J Kidney Dis 1995: 26: 643.
15. Fisher NC, Nightingale PG, Gunson BK, Lipkin GW, Neuberger JM. Chronic renal failure following liver transplantation: a retrospective analysis. Transplantation 1998: 66: 59.
16. Sehgal V, Radhakrishnan J, Appel GB, Valeri A, Cohen DJ. Progressive renal insufficiency following cardiac transplantation: cyclosporine, lipids, and hypertension. Am J Kidney Dis 1995: 26: 193.
17. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999: 10: 1136.
18. Myers BD. Cyclosporine nephrotoxicity. Kidney Int 1986: 30: 964.
19. Puschett JB, Greenberg A, Holley J, McCauley J. The spectrum of ciclosporin nephrotoxicity. Am J Nephrol 1990: 10: 296.
20. Bertani T, Ferrazzi P, Schieppati A et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991: 40: 243.
21. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003: 349: 931.
22. Herlitz H, Lindelow B. Renal failure following cardiac transplantation. Nephrol Dial Transplant 2000: 15: 311.
23. Lin J, Knight EL, Hogan ML, Singh AK. A comparison of prediction equations for estimating glomerular filtration rate in adults without kidney disease. J Am Soc Nephrol 2003: 14: 2573.
24. Levey ASGT, Kusek JW, Beck GJ, MDRD Study Group. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000: 11: 155A.
25. Lewis RM, Van Buren Ct, Radovancevic B et al. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients. J Heart Lung Transplant 1991: 10: 63.
26. Gonwa TA, Mai ML, Pilcher J et al. Stability of longterm renal function in heart transplant patients treated with induction therapy and low-dose cyclosporine. J Heart Lung Transplant 1992: 11: 926.
27. Zietse R, Balk AH, vd Dorpel MA, Meeter K, Bos E, Weimar W. Time course of the decline in renal function in cyclosporine-treated heart transplant recipients. Am J Nephrol 1994: 14: 1.
28. Tinawi M, Miller L, Bastani B. Renal function in cardiac transplant recipients: retrospective analysis of 133 consecutive patients in a single center. Clin Transplant 1997: 11: 1.
29. Goral S, Ynares C, Shyr Y, Yeoh TK, Johnson HK. Long-term renal function in heart transplant recipients receiving cyclosporine therapy. J Heart Lung Transplant 1997: 16: 1106.
30. Lindelow B, Bergh CH, Herlitz H, Waagstein F. Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol 2000: 11: 951.
31. van Gelder T, Balk AH, Zietse R, Hesse C, Mochtar B, Weimer W. Survival of heart transplant recipients with cyclosporine-induced renal insufficiency. Transplant Proc 1998: 30: 1122.
32. Satchithananda DK, Parameshwar J, Sharples L et al. The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. J Heart Lung Transplant 2002: 21: 651.
33. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984: 311: 699.
34. Myers BD, Sibley R, Newton L et al. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988: 33: 590.
35. Myers BD, Newton L, Boshkos C et al. Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 1988: 46: 694.
36. Myers BD, Newton L. Cyclosporine-induced chronic nephropathy: an obliterative microvascular renal injury. J Am Soc Nephrol 1991: 2: S45.
37. Ader JL, Tack I, Durand D, Tran-Van T, Rostaing L, Suc JM. Renal functional reserve in kidney and heart transplant recipients. J Am Soc Nephrol 1996: 7: 1145.
38. Stalder M, Birsan T, Hubble RW, Paniagua RT, Morris RE. In vivo evaluation of the novel calcineurin inhibitor ISATX247 in non-human primates. J Heart Lung Transplant 2003: 22: 1343.
39. Sanchez V, Delgado JF, Morales JM et al. Chronic cyclosporine-induced nephrotoxiciy in heart transplant patients: long-term benefits of treatment with mycophenolate mofetil and low-dose cyclosporine. Transplant Proc 2004: 36: 2823.
40. Groetzner J. Meiser B, Landwehr P et al. Mycophenolate mofetil and sirolimus as calcineurin inhibitor-free immunosuppression for late cardiac-transplant recipients with chronic renal failure. Transplantation 2004: 77: 568.
41. Groetzner J, Kaczmarek I, Landwehr P et al. Renal recovery after conversion to a calcineurin inhibitor-free immunosuppression in late cardiac transplant recipients. Eur J Cardiothorac Surg 2004: 25: 333.
42. Tedoriya T, Keogh Am, Kusano K et al. Reversal of chronic cyclosporine nephrotoxicity after heart transplantation-potential role of mycophenolate mofetil. J Heart Lung Transplant 2002: 21: 976.
43. Bunke M, Ganzel B. Effect of calcium channel antagonists on renal function in hypertensive heart transplant recipients. J Heart Lung Transplant 1992: 11: 1194.
44. Chan C, Maurer J, Cardella C, Cattran D, Pei Y. A randomized controlled trial of verapamil on cyclosporine nephrotoxicity in heart and lung transplant recipients. Transplantation 1997: 63: 1435.
45. Fassi A, Sangalli F, Colombi F, Perico N, Remuzzi G, Remuzzi A. Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine. Am J Kidney Dis 1999: 33: 267.
46. Elliot WJ, Murphy MB, Karp R. Long-term preservation of renal function in hypertensive heart transplant recipients treated with enalapril and a diuretic. J Heart Lung Transplant 1991: 10: 373.